Behnood Bikdeli is a Cardiology physician affiliated with Broad Institute. OpenAlex indexes 441 publications with 20,846 citations (h-index 46); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Boston, MA 021156106
Telephone
617-732-5500Provider last certified this registry record 19 Jan 2022.
Clinical trials
- Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19
Sponsor: Rajaie Cardiovascular Medical and Research Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
67.4%Statin28.2%Atorvastatin Calcium49%Rosuvastatin Calcium26%Pravastatin Sodium25%Part D<11 patientsBeta blocker15.6%Metoprolol Succinate69%Carvedilol31%Part D≥25 patients+ 7 more classes in this area
Blood & clotting
32.6%Factor Xa inhibitor30.1%Eliquis69%Xarelto31%Part D≥32 patientsP2Y12 inhibitor2.5%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease
Journal of the American College of Cardiology
2025 - International Clinical Practice Guideline Recommendations for Acute Pulmonary Embolism
Journal of the American College of Cardiology
2024 - When Direct Oral Anticoagulants Should Not Be Standard Treatment
Journal of the American College of Cardiology
2024 - Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes
Journal of the American College of Cardiology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Alan Mullen, MD, PhD
Broad Institute
Martin Pollak, MD
Broad Institute
Andrew Aguirre, MD, PhD
Broad Institute
Janey Wiggs, MD
Broad Institute
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”